null
SMILES: [#6]-[#8]-c1ccc(-[#6]-n2c(=O)nc(-[#7]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])n(-[#6]-c3ccc(-[#8]-[#6])nc3)c2=O)cc1
InChI Key: InChIKey=RYSVUBYTFQIRGS-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM50294603 (1-(2-(5-(4-methoxybenzyl)-1-((6-methoxypyridin-3-y...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | 51 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL | Assay Description Antagonist activity at human PKR1 expressed in HEK293 cells assessed as inhibition of PK1-induced calcium mobilization by FLIPR assay | Bioorg Med Chem Lett 19: 2661-3 (2009) Article DOI: 10.1016/j.bmcl.2009.03.157 BindingDB Entry DOI: 10.7270/Q23N23DG | |||||||||||
More data for this Ligand-Target Pair |